Sign in with Google. Opens in new tab
bullish
Akesobio (康方生物) Pre-IPO: Late in the PD-1 Game but Products Are Promising
669 Views03 Feb 2020 05:37
Akesobio is a clinical-stage biopharmaceutical company with a focus on developing biologics drugs for oncology and autoimmune. The company plans to...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 15-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- PointsBet (PBH AU): Betr's "Superior Offer"? In An Alternate Reality
- Xero (XRO AU): Index Flows Following the Capital Raise
- NIFTY200 Momentum30 Index Rebalance: HUGE Turnover and Trade as Financials Shine
- Shin Kong (2888 TT)/Taishin (2887 TT) - Short Timer, FX Risk, Index Flows - Time To Buy Vs Peers
- S&P/ASX Indices: Proposed Methodology Changes & The BIG September Rebalance
Top Unpaywalled Insights
More »- The New OS for Quant Finance: OpenBB, AI Agents & the Death of Legacy Terminals | New Barbarians ...
- Curator's Cut: Building Materials Moves, Benchmarking Gold Miners & Semaglutide in India and Japan
- [IO Technicals 2025/25] Bearish Momentum Strengthens
- VEON (VEON US): Launches Third Phase of Share Buyback Program After Share Pullback
- Valuations, Visas & Venture Pullback: An Equity + M&A Overview of the Education Sector in Q1 2025
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Akesobio (康方生物) Pre-IPO: Late in the PD-1 Game but Products Are Promising03 Feb 2020
- Okja: The Fight Between Netflix Vs. CJ CGV05 Jun 2017
- Netflix & Amazon Expand in Korea – Not a Coincidence20 Jan 2016
- Thoughts on Amazon –What Does Its Valuation Tells Us?01 Dec 2015
x